Evidence map›Paper›PMID 32122902›Full record

ArticleAntimicrobial agents and chemotherapy2020

Antimicrobial Activity of the Quinoline Derivative HT61 against Staphylococcus aureus Biofilms.

C J Frapwell, P J Skipp, R P Howlin, E M Angus, Y Hu, A R M Coates, R N Allan, J S Webb

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Unique structural and ligand-binding properties of theProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Unique structural and ligand binding properties of thebioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Bacterial persisters: molecular mechanisms and therapeutic development.Signal transduction and targeted therapy · 2024
    Review
  6. A Novel Peptide Antibiotic Produced byFrontiers in microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

C J FrapwellSchool of Biological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, United Kingdom.
P J SkippSchool of Biological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, United Kingdom.
R P HowlinSchool of Biological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, United Kingdom.
E M AngusBiomedical Imaging Unit, Southampton General Hospital, Southampton, United Kingdom.
Y HuInstitute of Infection and Immunity, St George's, University of London, London, United Kingdom.
A R M CoatesInstitute of Infection and Immunity, St George's, University of London, London, United Kingdom.
R N Allan *School of Biological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, United Kingdom.
J S Webb *School of Biological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, United Kingdom J.S.Webb@soton.ac.uk.
University of Southampton · GBHelperby Therapeutics (United Kingdom) · GBSouthampton General Hospital · GBSt George's, University of London · GB

Funding

Biotechnology and Biological Sciences Research Council BB/L016877/1Biotechnology and Biological Sciences Research Council BM/M012387/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsBiofilmsHumansMicrobial Sensitivity TestsQuinolinesStaphylococcal InfectionsStaphylococcus aureusVancomycinAnti-Bacterial AgentsHT61 compoundQuinolinesVancomycinantibioticsbiofilmsHT61proteomicsStaphylococcus aureus

Identifiers

PMID32122902
PMCPMC7179629
OpenAlexW3009296612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.